Would you go near a death bond?

Plans to ban traded life policy (TLP) investments may have consigned the products to the investment bin – but advocates say they offer benefits like no other asset class.

clock

Plans to ban traded life policy (TLP) investments may have consigned the products to the investment bin - but advocates say they offer benefits like no other asset class.

Toxic, dangerous, damaging and high risk – just some of the words used, including by the FSA, to describe traded life policy investments, or so-called ‘death bonds’. We may soon be able to add the following: banned The FSA may be delivered a death sentence of its very own to TLPs in November when it outlined plans to ban their sale and promotion. It even likened some policies to ‘ponzi’ schemes. Citing evidence of poor design and marketing, it said TLPs are unsuitable for most retail investors. A series of high-profile failures – most notably Keydata – have damaged the asset cla...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

Advisers zoomed in on capital accumulation in Q4 2025

Advisers zoomed in on capital accumulation in Q4 2025

Titan Square Mile research finds

Jen Frost
clock 30 January 2026 • 3 min read
Measure for measure: How to track your tracker fund

Measure for measure: How to track your tracker fund

Tracking difference and tracking error

Terry McGivern
clock 28 January 2026 • 3 min read
SJP and AJ Bell pivot from US mega-caps in MPS as concentration woes continue

SJP and AJ Bell pivot from US mega-caps in MPS as concentration woes continue

Healthcare, energy and EM preferred

Linus Uhlig
clock 28 January 2026 • 2 min read